Marol 150mg modified-release tablets (Teva)
BNF presentation 040702040BNAEAD within chapter Central Nervous System. Analyse prescribing behaviour, spending pressure, and high-usage pharmacies.
Product
Chemical substance
Chapter
Presentation code
040702040BNAEAD
Usage overview
Total items and spend derived from NHS dispensing data.
Items dispensed
13,293
NHS spend (£)
£112,553.46
Recent activity
March 2025
Monitor this presentation to understand cost pressures, availability challenges, and opportunities for clinical optimisation.
Dispensing trend
Month-by-month national usage.
| Month | Items dispensed |
|---|---|
| March 2025 | 1,702 |
| February 2025 | 9 |
| December 2024 | 450 |
| November 2024 | 1,844 |
| October 2024 | 1,906 |
| September 2024 | 7 |
| August 2024 | 177 |
| July 2024 | 2,020 |
| May 2024 | 505 |
| July 2021 | 828 |
| June 2021 | 519 |
| December 2020 | 1,526 |
Top pharmacies dispensing this medicine
Identify providers with the highest utilisation to focus engagement and support.
| Pharmacy | Items | Region |
|---|---|---|
| Unknown pharmacy | 95 | No data available |
| Unknown pharmacy | 56 | No data available |
| Unknown pharmacy | 54 | No data available |
| Unknown pharmacy | 46 | No data available |
| Unknown pharmacy | 41 | No data available |
| Unknown pharmacy | 39 | No data available |
| Unknown pharmacy | 36 | No data available |
| Unknown pharmacy | 35 | No data available |
| Unknown pharmacy | 33 | No data available |
| Unknown pharmacy | 32 | No data available |